Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Directorate Change

1 Apr 2025 17:05

RNS Number : 2194D
Maven Income & Growth VCT 4 PLC
01 April 2025
 

Maven Income and Growth VCT 4 PLC

 

Directorate Changes

 

Appointment of Director

 

The Board of Maven Income and Growth VCT 4 PLC (the Company) is pleased to announce the appointment of Daniel Bittner as an independent Non-executive Director, with effect from 1 April 2025.

 

Daniel has an MBA from the University of St Gallen and worked in the financial sector with JP Morgan, Morgan Stanley and Goldman Sachs before founding the Rhino Partners Real Estate Group in Germany, and acting as a board advisor to Alpha Credit, a Geneva based private debt specialist. In 2002, he founded Arsago Capital Partners AG, of which he is chief executive, where he has managed direct and portfolio investments, including a global macro hedge fund, equity funds, a fixed income arbitrage fund, private equity investments, debt financing and venture capital mining companies.

 

During his career, Daniel has gained experience in business development, deal sourcing, investment valuation and oversight, and the structuring and risk assessment of investment portfolios. He has also managed funds, developed investment strategies, assessed project feasibility studies and overseen the execution of real estate and mining projects, as well as providing services as an investment advisor, focusing on private equity investments in the commodity, energy, real estate and technology sectors.

 

Daniel will serve on the Company's Audit, Management Engagement, Nomination and Risk Committees, and will stand for election by Shareholders at the Annual General Meeting (AGM) to be held on 8 May 2025.

 

As at the date of this announcement, Daniel has no current beneficial interest in the Company's Ordinary Shares and, in relation to his appointment, there is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 R.

 

Retirement of Director

As required by Listing Rule 9.6.11, the Company also confirms that Steven Scott, who has served as an independent Non-executive Director since 1 September 2004 and as Chair of the Audit Committee, has decided to retire at the conclusion of the 2025 AGM and will not stand for re-election.

 

The Board would like to thank Steven for his many years of commitment to the Company in his role as Non-executive Director and as Chair of the Audit Committee, and wishes him every success for the future.

 

Following Steven's retirement, Brian Colquhoun will assume the role of Chair of the Audit Committee.

 

Maven Capital Partners UK LLP

Company Secretary

 

1 April 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUARNRVOUSRAR
Date   Source Headline
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme
20th Aug 20154:50 pmRNSTransaction in Own Shares
20th Aug 201511:47 amRNSStatement re Net Asset Value and Dividend
23rd Jun 20154:51 pmRNSTransaction in Own Shares
12th Jun 201510:02 amRNSIssue of Equity
5th Jun 20153:18 pmRNSNet Asset Value(s)
27th May 20159:34 amRNSTransaction in Own Shares
15th May 20152:17 pmRNSTransaction in Own Shares
14th May 201512:38 pmRNSTransaction in Own Shares
13th May 20153:21 pmRNSTransaction in Own Shares
12th May 20154:39 pmRNSNet Asset Value(s)
29th Apr 20152:13 pmRNSDirectorate Change
29th Apr 20152:13 pmRNSResult of AGM
13th Apr 20153:12 pmRNSIssue of Equity
30th Mar 20152:26 pmRNSTransaction in Own Shares
26th Mar 201512:52 pmRNSTransaction in Own Shares
25th Mar 20152:38 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.